Literature DB >> 11017724

Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.

C Farenc1, J R Fabreguette, F Bressolle.   

Abstract

This paper presents a new software, Pk-fit, to fit nonlinear models to kinetic and dynamic data. Directly connected to the spreadsheet, a statistical software component manager is available. In the data manager, Pk-fit includes the noncompartmental analysis module, the compartmental analysis module, the nonlinear kinetic process module, the drug absorption module, the pharmacodynamic data modeling module, the simultaneous fitting module, and the user-defined library module. In this paper, we present a detailed comparison of the kinetic analysis using Pk-fit and common software packages, PCNONLIN, MODFIT, MKMODEL, NONMEM, and SIPHAR, based on the textbook published by Gabrielsson in 1992, "Compilation of Analyzed Data Sets for Pharmacokinetic Software Evaluation." The comparison of Pk-fit with the reference softwares revealed that the parameters and their dispersion found with Pk-fit are consistent with the ones estimated with the other programs. In conclusion, Pk-fit constituted a valid tool for pharmacokinetic/pharmacodynamic data analysis. Copyright 2000 Academic Press.

Mesh:

Year:  2000        PMID: 11017724     DOI: 10.1006/cbmr.2000.1548

Source DB:  PubMed          Journal:  Comput Biomed Res        ISSN: 0010-4809


  8 in total

1.  Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.

Authors:  Youssef Hijazi; Carole Bodonian; François Salord; Françoise Bressolle; Roselyne Boulieu
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

2.  Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.

Authors:  A Gaudard; E Varlet-Marie; M Audran; R Gomeni; F Bressolle
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.

Authors:  Salomé Payen; Albert Faye; Alexandra Compagnucci; Carlo Giaquinto; Diana Gibbs; Roberto Gomeni; Françoise Bressolle; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.

Authors:  Olivier Nicolas; Delphine Margout; Nicolas Taudon; Sharon Wein; Michèle Calas; Henri J Vial; Françoise M M Bressolle
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  High Accumulation and In Vivo Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite Death.

Authors:  Sharon Wein; Nicolas Taudon; Marjorie Maynadier; Christophe Tran Van Ba; Delphine Margout; Yann Bordat; Laurent Fraisse; Kai Wengelnik; Rachel Cerdan; Françoise Bressolle-Gomeni; Henri J Vial
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Integrated software environment based on COMKAT for analyzing tracer pharmacokinetics with molecular imaging.

Authors:  Yu-Hua Dean Fang; Pravesh Asthana; Cristian Salinas; Hsuan-Ming Huang; Raymond F Muzic
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

7.  Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action.

Authors:  Catherine Mullié; Alexia Jonet; Camille Desgrouas; Nicolas Taudon; Pascal Sonnet
Journal:  Malar J       Date:  2012-03-08       Impact factor: 2.979

8.  In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism.

Authors:  Marie L Ancelin; Michèle Calas; Anne Bonhoure; Serge Herbute; Henri J Vial
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.